Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Clinical Pharmacology
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Clinical Pharmacology
    Intravenous Acetaminophen Reduces Pain, Opioid Consumption After Hip or Knee Surgery: Presented at AAPM - (DGDispatch)
    Methylnaltrexone for Opioid-Induced Constipation Does Not Adversely Affect Pain, Withdrawal Symptoms: Presented at AAPM - (DGDispatch)
    Sodium Oxybate Improves Pain, Function in Patients With Fibromyalgia: Presented at AAPM - (DGDispatch)
    Health Canada Approves Darunavir for Children, Adolescents With HIV - (DGNews)
    Rosuvastatin Approved for US Adults With No Clinically Evident Cardiovascular Disease - (DGNews)

    News archive

     Recent webcasts/CME - Clinical Pharmacology
    • Translating Guidelines Into Practice: An Expert Roundtable Discussion of Optimal Antiplatelet Therapy in Acute Coronary Syndrome
    • Current State of the Art in Antiplatelet Therapy in Clinical Practice: Results From the Field
    • The Future of Antiplatelet Therapy in Patients With ACS: Can We See it From Here?
    • Tools for Supporting Optimal Fibromyalgia Diagnosis and Treatment: An Update for Primary Care and Managed Care
      Deep Vein Thrombosis in Focus: Expert Perspectives on Reducing the Burden of Venous Thromboembolism

      Webcasts/CME archive

       Recent cases - Clinical Pharmacology
        The Influence Of Hepatitis C Infection And Interferon-alpha Therapy On Thyrotropin Blocking And Stimulating Autoantibodies In Graves' Ophthalmopathy: A Case Report
        Sigma-1 Receptor Agonist Fluvoxamine For Delirium In Patients With Alzheimer's Disease
        Olanzapine And Pulmonary Embolism, A Rare Association: A Case Report
        Anti-Inflammatory Effects Of Antidepressant And Atypical Antipsychotic Medication For The Treatment Of Major Depression And Comorbid Arthritis: A Case Report
        Etanercept And Venous Thromboembolism: A Case Series

        Cases archive
          




        my personal edition > clinical pharmacology > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Methylphenidate (Ritalin) With Alcohol Appears to Raise Blood Pressure in Adults: Presented at ACCP

        By Crystal Phend

        WASHINGTON, DC -- September 13, 2005 -- Methylphenidate (Ritalin) appears to have a larger effect on females and both genders experience an increase in blood pressure when the drug is combined with even one dose of alcohol, according to results of a small randomized study.

        "We need to be concerned about adults taking methylphenidate and then drinking," said presenter Robin R. Minhinnett, PharmD candidate, Medical University of South Carolina, Charleston, South Carolina, United States.

        The study was led by Kennerly S. Patrick, Professor of Pharmaceutical Sciences, Medical University of South Carolina.

        Fatal overdoses of methylphenidate (MPH) have occurred in at least two college students who took it with alcohol, Minhinnett said at the annual meeting of the American College of Clinical Pharmacology (ACCP) here on September 11th. These cases led to the discovery of an isomer that when combined with alcohol is similar to those found in cocaine, she said.

        For the study, researchers enrolled healthy adults, 10 male and 10 female, who were given 0.3 mg/kg MPH in a randomized crossover design, with subject participating in each of the three phases of treatment -- MPH was administered 30 minutes before receiving 0.6 g/kg of ethanol; MPH 30 minutes after 0.6 g/kg of ethanol; and MPH alone.

        Blood samples and vital signs were obtained as well as self and observer scoring on items such as anxiety, feeling of intoxication and "feeling high."

        Results show that alcohol significantly increased the rate of absorption and the maximum plasma values of MPH. Blood pressure was elevated significantly when ethanol was taken after MPH; systolic blood pressure increased by about 5 mm Hg and diastolic by about 3 mm Hg compared to control measurements with MPH alone. This effect by itself probably would not be considered dangerous but additional drinks could raise the cardiovascular risk, Minhinnett said.

        Women reported significantly more feelings of intoxication and depression than did men with or without alcohol.

        "This drug sensitivity could constitute a gender-based differential vulnerability to MPH abuse," the researchers concluded.

        [Presentation title: Influence of Ethanol and Gender on Methylphenidate Bioavailability, Metabolism and Response. Abstract 67]




        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2010 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send